This week, the FDA will decide whether to approve Vertex Pharmaceuticals' non-opioid painkiller. Vertex believes pain could ...
Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...
A novel once-daily drug showed a comparable efficacy and safety profile as the standard-of-care drug in patients with cystic ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with its substantial $114.5 billion market capitalization, continues to dominate the cystic fibrosis (CF) treatment market while advancing a ...
The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...
Irish Independent on MSN1d
Wicklow mother calls for access to life-saving therapy for son with rare form of Cystic FibrosisA Wicklow mother is among a concerned group of parents who are calling for individual trials of the modulator therapies for ...
The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...
Some people with cystic fibrosis still do not have access to the life-changing modulator therapy drugs, despite wider EMA ...
I’m A Celebrity…Get Me Out Of Here star Reggie Bird has opened up about caring for her son with cystic fibrosis and says she ...
GlobalData on MSN6d
Glox to develop precision antibiotics for cystic fibrosis"Glox to develop precision antibiotics for cystic fibrosis" was originally created and published by Pharmaceutical Technology ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback